Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
WallabyPhenox
WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial
March 20, 2026
WallabyPhenox Restructures Debt and Accelerates Global Growth
March 18, 2026